Sydney, July 26, 2007 (ABN Newswire) - Avexa Limited (ASX: AVX) - Releases ATC Phase IIb Clinical Trial Update - Dr Jonathan Coates, Chief Scientific Officer and Dr Susan Cox, Head of Development; Avexa Limited (ASX: AVX) present the following audio webcast regarding "Dr Jonathan Coates, Chief Scientific Officer and Dr Susan Cox, Head of Development". You may also download this audio webcast to your computer or portable audio player.
Research and development of anti-infective treatments for HIV, Hepatitis B and antibiotic resistant bacteria.Non Exec. Director: Dr John Sime Non Exec. Director: Mr Stephen Cooper Executive Director, CEO: Dr Julian J. Chick Chairman: Dr Hugh D. Niall CFO: Mr Alan Boyd
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: Avexa Limited (ASX: AVX)
Broadcast Title: Dr Jonathan Coates, Chief Scientific Officer and Dr Susan Cox, Head of Development
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Avexa Limited (ASX: AVX) below.
http://abnnewswire.net/vlnk/0B1F4N24
About AVEXA LIMITED
Research and development of anti-infective treatments for HIV, Hepatitis B and antibiotic resistant bacteria.
News 
